Table S1 - Evaluation of the Antitumor Effects of BPR1J-340, a Potent and Selective FLT3 Inhibitor, Alone or in Combination with an HDAC Inhibitor, Vorinostat, in AML Cancer
收藏数据链接：
官方服务：
资源简介：
Kinase inhibition profiles of BPR1J-340. Percentage inhibition was determined by Invitrogen SelectScreen kinase profiling service. (XLS)
创建时间：
2015-12-02
相关数据集
暂无相关数据集
